Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the Severe Asthma Network in Italy (SANI)
According to the data derived from several national and international registries, including SANI (Severe Asthma Network Italy), and considering the strong impact that frequent or regular use of oral corticosteroid has on quality of life (QoL) of severe asthmatics, as well as on the costs for managin...
Similar Items
-
Patient and physician perspectives on biological treatment in severe asthma: a Severe Asthma Network Italy survey
by: Claudia Crimi, et al.
Published: (2023-11-01) -
Economic impact of a more extensive use of FENO testing on the Italian population with asthma
by: Carla Rognoni, et al.
Published: (2023-06-01) -
Biologics in Severe Eosinophilic Asthma: Three-Year Follow-Up in a SANI Single Center
by: Paolo Solidoro, et al.
Published: (2022-01-01) -
Critical evaluation of asthma biomarkers in clinical practice
by: Giuseppe Guida, et al.
Published: (2022-10-01) -
Nasal polyps impact in severe asthma patients: evidences from the SANI
by: Giorgio Walter Canonica, et al.
Published: (2020-08-01)